drugset / Trial / NCT02972268

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

NCT02972268

Phase 3 Completed 780 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

Clinical Trial to Compare the Efficacy and Safety of Solifenacin/Tamsulosin Combination Therapy with Tamsulosin Monotherapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

Timeline

Start
2016-02-01
Primary completion
2017-11-02
Completion
2018-08-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 5 mg
Background Tamsulosin Other / unclassified 0.2 mg